Laurion Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Laurion Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-337,105	Closed	-$31.3M	–	774
2021 Q4	$31.3M	Sell	337,105 -15,235	-4%	-$1M	0.32%	54
2021 Q3	$21M	Buy	352,340 +100,000	+40%	+$5.91M	0.09%	199
2021 Q2	$17.2M	Hold	252,340	–	–	0.1%	158
2021 Q1	$17.5M	Sell	252,340 -81,111	-24%	-$6.24M	0.09%	180
2020 Q4	$25.6M	Buy	333,451 +33,451	+11%	+$2.51M	0.2%	115
2020 Q3	$22.4M	Buy	+300,000	New	+$20M	0.27%	92
2020 Q1	–	Sell	-14,400	Closed	-$654K	–	1193
2019 Q4	$654K	Buy	+14,400	New	+$681K	0.01%	647
2018 Q4	–	Sell	-21,248	Closed	-$978K	–	1525
2018 Q3	$978K	Buy	+21,248	New	+$861K	0.01%	697

Laurion Capital Management's ARNA Position: Q1 2022 in Review

Laurion Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 337,105 shares — an estimated $31.3M sold.

Laurion Capital Management first reported a position in ARNA in Q3 2018 and held it in 8 quarters. The position peaked at $31.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Laurion Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Laurion Capital Management sold 337,105 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $31.3M.
Laurion Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 8 quarters.
Laurion Capital Management's Arena Pharmaceuticals Inc position peaked at $31.3M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Laurion Capital Management's 13F filing for Q1 2022, filed 16 May 2022.